Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:collaboratesWith |
gptkb:Karyopharm_Therapeutics
|
| gptkbp:focusesOn |
oncology
hematology |
| gptkbp:foundedBy |
gptkb:Dr._Jay_Mei
|
| gptkbp:foundedYear |
2017
|
| gptkbp:headquartersLocation |
gptkb:Shanghai,_China
|
| https://www.w3.org/2000/01/rdf-schema#label |
Antengene
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:keyPerson |
gptkb:Dr._Jay_Mei
|
| gptkbp:mission |
to discover and develop innovative medicines for cancer and other life-threatening diseases
|
| gptkbp:numberOfEmployees |
over 200
|
| gptkbp:product |
gptkb:ATG-008_(onatasertib)
gptkb:ATG-010_(selinexor) gptkb:ATG-016 gptkb:ATG-037 gptkb:ATG-101 |
| gptkbp:servesArea |
gptkb:United_States
gptkb:Asia-Pacific |
| gptkbp:stockExchange |
gptkb:Hong_Kong_Stock_Exchange
|
| gptkbp:stockSymbol |
gptkb:6996.HK
|
| gptkbp:website |
https://www.antengene.com/
|
| gptkbp:bfsParent |
gptkb:Zhangjiang
|
| gptkbp:bfsLayer |
6
|